Seroprevalence and risk factors of hepatitis E virus infection among children in China

Journal of Medical Virology

Volumn 87, Issue 9, 2015, Pages 1573-1577

  Meng, Qing Feng ^a   You, Hai Long ^b   Wang, Wei Li ^a   Zhou, Na ^c   Dong, Wei ^d   Cong, Wei ^e  

^a Jilin Entry Exit Inspection and Quarantine Bureau   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

^d Weihaiwei People's Hospital   (China)

^e JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

A cross sectional study; Children; China; Hepatitis E virus; Seroprevalence

Indexed keywords

DRINKING WATER; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGE; ARTICLE; CHILD; CHINA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RURAL AREA; SEROPREVALENCE; URBAN AREA; VIRUS TRANSMISSION; ADOLESCENT; ANIMAL; BLOOD; DEMOGRAPHY; IMMUNOLOGY; INFANT; PIG; PRESCHOOL CHILD; RISK FACTOR; TRANSMISSION;

HEPATITIS E VIRUS; SUIDAE;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SWINE;

EID: 84937074030     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24203     Document Type: Article

References (21)

1. Alvarado-Esquivel C, Torres-Berumen JL, Estrada-Martínez S, Liesenfeld O, Mercado-Suarez MF. 2011. Toxoplasma gondii infection and liver disease: A case-control study in a northern Mexican population. Parasit Vectors 4:75.
2. Buti M, Plans P, Domínguez A, Jardi R, Rodriguez Frias, Salleras R, Plasencia L, . 2008. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 15:732-734.
3. Caron M, Kazanji M. 2008. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 5:158.
4. Cevahir N, Demir M, Bozkurt AI, Ergin A, Kaleli I. 2013. Seroprevalence of hepatitis e virus among primary school children. Pak J Med Sci 29:629-632.
5. Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, Choutet P, Garcia-Bonnet N, Coursaget P. 2013. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 58:504-508.
6. Cong W, Liu GH, Meng QF, Dong W, Qin SY, Zhang FK, Zhang XY, Wang XY, Qian AD, Zhu XQ. 2015. Toxoplasma gondii infection in cancer patients: Prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett 359:307-313.
7. Cong W, Meng QF, Li B, Ma FL, Qian AD, Wang XY, Yu CZ, Zhu XQ. 2014a. Seroprevalence of hepatitis E virus infection in psychiatric patients and control subjects in Shandong Province, eastern China. Int J Infect Dis 28C:70-73.
8. Cong W, Sui JC, Zhang XY, Qian AD, Chen J, Zhu XQ. 2014b. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China. J Med Virol 87: 446-450.
9. Davaalkham D, Enkhoyun T, Takahashi M, Nakamura Y, Okamoto H. 2009. Hepatitis A and E virus infections among children in Mongolia. Am J Trop Med Hyg 81:248-251.
10. Dong C, Dai X, Liang J, Dong M, Meng J. 2012. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon 12:386-390.
11. Jia Z, Yi Y, Liu J, Cao J, Zhang Y, Tian R, Yu T, Wang H, Wang X, Su Q, Zhou W, Cui F, Liang X, Bi S. 2014. Epidemiology of hepatitis e virus in China: Results from the third national viral hepatitis prevalence survey, 2005-2006. PLoS One 9:e110837.
12. Khuroo MS, Kamili S. 2003. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 10:61-69.
13. Krumbholz A, Neubert A, Joel S, Girschick H, Huppertz HI, Kaiser P, Liese J, Streng A, Niehues T, Peters J, Sauerbrey A, Schroten H, Tenenbaum T, Wirth S, Zell R, Sauerbrei A. 2014. Prevalence of hepatitis E virus antibodies in children in Germany. Pediatr Infect Dis J 33:258-262.
14. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. 2012. Hepatitis E. Lancet 379:2477-2488.
15. Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: The current scenario. Int J Infect Dis 17:e228-e233.
16. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE. 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8:e61351.
17. Lin DB, Lin JB, Chen SC, Yang CC, Chen WK, Chen CJ. 2004. Seroepidemiology of hepatitis E virus infection among preschool children in Taiwan. J Med Virol 74:414-418.
18. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-2312.
19. Mushahwar IK. 2008. Hepatitis E virus: Molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80:646-658.
20. Pelosi E, Clarke I. 2008. Hepatitis E: A complex and global disease. Emerg Health Threats J 1:e8.
21. Ren F, Zhao C, Wang L, Wang Z, Gong X, Song M, Zhuang H, Huang Y, Shan H, Wang J, Liu Q, Ness P, Nelson KE, Wang Y. 2014. Hepatitis E virus seroprevalence and molecular study among blood donors in China. Transfusion 54:910-917.